BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33169562)

  • 1. [Overview of novel coronavirus infection and replication].
    He L; Liu W; Li J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1961-1969. PubMed ID: 33169562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
    Muchtaridi M; Fauzi M; Khairul Ikram NK; Mohd Gazzali A; Wahab HA
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32882868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.
    Asghari A; Naseri M; Safari H; Saboory E; Parsamanesh N
    DNA Cell Biol; 2020 Oct; 39(10):1741-1753. PubMed ID: 32716648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging coronaviruses: Genome structure, replication, and pathogenesis.
    Chen Y; Liu Q; Guo D
    J Med Virol; 2020 Apr; 92(4):418-423. PubMed ID: 31967327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 (COVID-19) by the numbers.
    Bar-On YM; Flamholz A; Phillips R; Milo R
    Elife; 2020 Apr; 9():. PubMed ID: 32228860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
    Bergmann CC; Silverman RH
    Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current landscape of coronavirus-host protein-protein interactions.
    Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO
    J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronaviruses and gastrointestinal diseases.
    Luo X; Zhou GZ; Zhang Y; Peng LH; Zou LP; Yang YS
    Mil Med Res; 2020 Oct; 7(1):49. PubMed ID: 33054860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.